Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Wan

Showing results (31-40 of 78) with videos related to

Pageof 8
Sort By:
Nuclear Medicine Communications|January 3, 2020
The value of 18F-FDG PET-CT and 131I-norcholesterol scintigraphy in the characterization of high-risk adrenal massesSaima Riaz, Rizwan Syed, Tarek Abdel Aziz, et al.
Internal Medicine Journal|July 23, 2025
Clinico-pathologic characteristics, updated diagnostic approach and value of positron emission tomography for adults with splenomegaly at a large, university hospitalHuw Richards, Adam Gray, Jawad Saeed, et al.
Nuclear Medicine Communications|January 23, 2025
Patients, parents and professional perspectives on molecular radiotherapy for neuroblastoma and paediatric neuroendocrine cancersLisa Whittaker, Leona Knox, Zara Aitchison, et al.
Nuclear Medicine Communications|October 30, 2023
BNMS UK PET standardsGary J R Cook, John Dickson, Sugama Chicklore, et al.
Frontiers in Oncology|August 19, 2021
Radiomics-Based Texture Analysis of <sup>68</sup>Ga-DOTATATE Positron Emission Tomography and Computed Tomography Images as a Prognostic Biomarker in Adults With Neuroendocrine Cancers Treated With <sup>177</sup>Lu-DOTATATECharlotte Atkinson, Balaji Ganeshan, Raymond Endozo, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 8, 2020
COVID-19 in the act: incidental 18F-FDG PET/CT findings in asymptomatic patients and those with symptoms not primarily correlated with COVID-19 during the United Kingdom coronavirus lockdownRichard Halsey, Dimitrios Priftakis, Strachan Mackenzie, et al.
European Radiology|January 14, 2022
Application of diffusion-weighted whole-body MRI for response monitoring in multiple myeloma after chemotherapy: a systematic review and meta-analysisKaiwen Wang, Elsa Lee, Shedrack Kenis, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 27, 2026
Multidisciplinary team interpretation performance for indeterminate bone uptake on PSMA PET during prostate cancer staging: Comparison with PROMISE criteriaDimitrios Priftakis, Fadilah Aziz, Noora Bin Essa, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 12, 2020
A phase IIa trial of molecular radiotherapy with 177-lutetium DOTATATE in children with primary refractory or relapsed high-risk neuroblastomaJennifer E Gains, Veronica Moroz, Matthew D Aldridge, et al.
Oral Oncology|October 19, 2024
Incidence and predictive factors for positive non-sentinel lymph nodes in completion neck dissection following a positive sentinel node biopsy in early oral cancerSearan Karamchandani, Axel Sahovaler, Elizabeth Crosbie-Jones, et al.
Pageof 8

Showing results (31-40 of 78) with videos related to

Sort By:
Pageof 8
Nuclear Medicine Communications|January 3, 2020
The value of 18F-FDG PET-CT and 131I-norcholesterol scintigraphy in the characterization of high-risk adrenal massesSaima Riaz, Rizwan Syed, Tarek Abdel Aziz, et al.
Internal Medicine Journal|July 23, 2025
Clinico-pathologic characteristics, updated diagnostic approach and value of positron emission tomography for adults with splenomegaly at a large, university hospitalHuw Richards, Adam Gray, Jawad Saeed, et al.
Nuclear Medicine Communications|January 23, 2025
Patients, parents and professional perspectives on molecular radiotherapy for neuroblastoma and paediatric neuroendocrine cancersLisa Whittaker, Leona Knox, Zara Aitchison, et al.
Nuclear Medicine Communications|October 30, 2023
BNMS UK PET standardsGary J R Cook, John Dickson, Sugama Chicklore, et al.
Frontiers in Oncology|August 19, 2021
Radiomics-Based Texture Analysis of <sup>68</sup>Ga-DOTATATE Positron Emission Tomography and Computed Tomography Images as a Prognostic Biomarker in Adults With Neuroendocrine Cancers Treated With <sup>177</sup>Lu-DOTATATECharlotte Atkinson, Balaji Ganeshan, Raymond Endozo, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 8, 2020
COVID-19 in the act: incidental 18F-FDG PET/CT findings in asymptomatic patients and those with symptoms not primarily correlated with COVID-19 during the United Kingdom coronavirus lockdownRichard Halsey, Dimitrios Priftakis, Strachan Mackenzie, et al.
European Radiology|January 14, 2022
Application of diffusion-weighted whole-body MRI for response monitoring in multiple myeloma after chemotherapy: a systematic review and meta-analysisKaiwen Wang, Elsa Lee, Shedrack Kenis, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 27, 2026
Multidisciplinary team interpretation performance for indeterminate bone uptake on PSMA PET during prostate cancer staging: Comparison with PROMISE criteriaDimitrios Priftakis, Fadilah Aziz, Noora Bin Essa, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 12, 2020
A phase IIa trial of molecular radiotherapy with 177-lutetium DOTATATE in children with primary refractory or relapsed high-risk neuroblastomaJennifer E Gains, Veronica Moroz, Matthew D Aldridge, et al.
Oral Oncology|October 19, 2024
Incidence and predictive factors for positive non-sentinel lymph nodes in completion neck dissection following a positive sentinel node biopsy in early oral cancerSearan Karamchandani, Axel Sahovaler, Elizabeth Crosbie-Jones, et al.
Pageof 8